-
1301
-
1302
Prediction and Risk Factors for Prognosis of Cirrhotic Patients with Hepatic Encephalopathy
Published 2021-01-01“…Acute-on-chronic liver failure (ACLF) mainly occurs in patients with chronic liver diseases and often presents with HE. Several predictive models have been proposed to predict the outcomes of these patients. …”
Get full text
Article -
1303
Resolved Hepatitis B: Achieved or Imaginary Wellbeing?
Published 2021-04-01“…PHB with chronic liver diseases of various aetiology significantly rises the risk of cirrhosis and hepatic cancer. …”
Get full text
Article -
1304
-
1305
-
1306
Nuclear receptors in regulation of bile acids transport and metabolism
Published 2013-10-01“…Accumulation of BA and other bile components in hepatocytes during cholestatic liver diseases is accompanied by liver cells damage and ready to fibrosis and cirrhosis. …”
Get full text
Article -
1307
Canadian Association of Gastroenterology Practice Guidelines: Evaluation of Abnormal Liver Enzyme Tests
Published 1998-01-01Get full text
Article -
1308
Stability Analysis and Clinic Phenomenon Simulation of a Fractional-Order HBV Infection Model
Published 2020-01-01Get full text
Article -
1309
Structural studies of the IFNλ4 receptor complex using cryoEM enabled by protein engineering
Published 2025-01-01Get full text
Article -
1310
Akkermansia muciniphila Mediated the Preventive Effect of Disulfiram on Acute Liver Injury via PI3K/Akt Pathway
Published 2025-01-01“…The enterohepatic axis is one of the targets of recent attention due to its important role in liver diseases. Disulfiram (DSF) is a multitarget drug that has been proven to play a role in a variety of liver diseases and can affect intestinal flora, but whether it can alleviate ALI is not clear. …”
Get full text
Article -
1311
Mesenchymal stromal cell-derived extracellular vesicles as nanotherapeutics for concanavalin a-induced hepatitis: modulating the gut‒liver axis
Published 2025-01-01“…Abstract Background As cell-free nanotherapeutics, extracellular vesicles derived from mesenchymal stem cells (MSC-EVs) have shown potential therapeutic action against liver diseases. However, their effects on autoimmune hepatitis (AIH) are not yet well understood. …”
Get full text
Article -
1312
Esophageal Varices: Pathophysiology, Approach, and Clinical Dilemmas
Published 2012-01-01Get full text
Article -
1313
Treatment of intractable pruritus in patients with cholestasis with molecular adsorbents recirculating system dialysis: a case series
Published 2021-09-01“…Pruritus commonly occurs in patients with cholestatic liver diseases. Pruritus that is refractory to pharmacological treatment may be an indication for liver transplantation [1–3]. …”
Get full text
Article -
1314
The theses for MD degree
Published 2011-02-01“…Idrisova – Value of a latent HBV-infection in progression of chronic liver diseases.T.A. Batyukhno - Chronic pancreatitis: disorders of protective immune mechanisms and their pharmacological treatment.S.P. …”
Get full text
Article -
1315
Intractable Fasting Hypoglycemia as a Manifestation of Hepatocellular Carcinoma
Published 2017-01-01“…Non-islet cell tumor hypoglycemia (NICTH) is a rare and serious paraneoplastic complication of both malignant and benign tumors to consider when evaluating fasting hypoglycemia, especially in the setting of liver diseases. We present a case of NICTH in a 54-year-old male with hepatocellular carcinoma (HCC) who presented with symptomatic intractable hypoglycemia (IH) after bowel preparation and fasting for screening upper endoscopy and colonoscopy.…”
Get full text
Article -
1316
Impact of population screening for Lynch syndrome insights from the All of Us data
Published 2025-01-01Get full text
Article -
1317
Advances in liver organoids: replicating hepatic complexity for toxicity assessment and disease modeling
Published 2025-01-01“…The liver organoids also serve as ideal platforms for studying liver diseases such as hepatitis, liver fibrosis, viral liver diseases, and monogenic diseases. …”
Get full text
Article -
1318
The Effect of an Aqueous Extract of Teucrium polium on Glutathione Homeostasis In Vitro: A Possible Mechanism of Its Hepatoprotectant Action
Published 2010-01-01“…Teucrium polium is used in Arab traditional medicine to treat liver diseases. Glutathione is an important intracellular antioxidant, and intrahepatic glutathione levels are depleted in liver diseases. …”
Get full text
Article -
1319
-
1320